DIA
RCKT icon

Dana Investment Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Dana Investment Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,638
Closed -$118K – 556
2025
Q1 		$118K Buy
17,638
+30
+0.2% +$296 ﹤0.01% 537
2024
Q4 		$221K Buy
17,608
+2,627
+18% +$39.5K 0.01% 527
2024
Q3 		$277K Buy
14,981
+1,134
+8% +$23.2K 0.01% 500
2024
Q2 		$298K Buy
13,847
+586
+4% +$13.5K 0.01% 482
2024
Q1 		$357K Sell
13,261
-156
-1% -$4.43K 0.01% 470
2023
Q4 		$402K Sell
13,417
-1,992
-13% -$44K 0.02% 343
2023
Q3 		$316K Sell
15,409
-1,315
-8% -$23.9K 0.02% 357
2023
Q2 		$332K Buy
16,724
+931
+6% +$18.8K 0.02% 355
2023
Q1 		$271K Buy
15,793
+1,420
+10% +$27.8K 0.01% 363
2022
Q4 		$281K Buy
+14,373
New +$265K 0.01% 368

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return